Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth

Abstract— During angiogenesis, microvascular endothelial cells (ECs) secrete proteinases that permit penetration of the vascular basement membrane as well as the interstitial extracellular matrix. This study tested the hypothesis that cathepsin S (Cat S) contributes to angiogenesis. Treatment of cultured ECs with inflammatory cytokines or angiogenic factors stimulated the expression of Cat S, whereas inhibition of Cat S activity reduced microtubule formation by impairing cell invasion. ECs from Cat S–deficient mice showed reduced collagenolytic activity and impaired invasion of collagens type I and IV. Cat S–deficient mice displayed defective microvessel development during wound repair. This abnormal angiogenesis occurred despite normal vascular endothelial growth factor and basic fibroblast growth factor levels, implying an essential role for extracellular matrix degradation by Cat S during microvessel formation. These results demonstrate a novel function of endothelium-derived Cat S in angiogenesis.

[1]  L. Devy,et al.  The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  C. Peters,et al.  Degradation of Mouse Invariant Chain: Roles of Cathepsins S and D and the Influence of Major Histocompatibility Complex Polymorphism , 1997, The Journal of experimental medicine.

[3]  J. Kos,et al.  Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis , 2001, British Journal of Cancer.

[4]  P. Libby,et al.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.

[5]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[6]  R. Maciewicz,et al.  A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. , 1988, The Biochemical journal.

[7]  D. Rich,et al.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. , 1992, The Journal of biological chemistry.

[8]  H. Ploegh,et al.  Secreted cathepsin L generates endostatin from collagen XVIII , 2000, The EMBO journal.

[9]  A. Pozzi,et al.  Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Kuzuya,et al.  Inhibition of angiogenesis on glycated collagen lattices , 1998, Diabetologia.

[11]  K. Yoshino,et al.  Matrix Metalloproteinase and αvβ3 Integrin–Dependent Vascular Smooth Muscle Cell Invasion Through a Type I Collagen Lattice , 2000 .

[12]  J. Winer,et al.  Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. , 1992, The Journal of biological chemistry.

[13]  J. Tímár,et al.  Role of elastin-matrix interactions in tumor progression. , 2002, Seminars in cancer biology.

[14]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[15]  G. Dranoff,et al.  Cathepsin S required for normal MHC class II peptide loading and germinal center development. , 1999, Immunity.

[16]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[17]  G. Nackman,et al.  Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. , 1997, Surgery.

[18]  L. Lund,et al.  Impaired wound healing in mice with a disrupted plasminogen gene , 1996, Nature Medicine.

[19]  Koichiro Yoshino,et al.  Induction of apoptotic cell death in vascular endothelial cells cultured in three-dimensional collagen lattice. , 1999, Experimental cell research.

[20]  M. Dewhirst,et al.  Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  G. Bieler,et al.  Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ , 1998, Nature Medicine.

[22]  D. Benezra.  Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. , 1997, Investigative ophthalmology & visual science.

[23]  S. Weiss,et al.  Regulation of Elastinolytic Cysteine Proteinase Activity in Normal and Cathepsin K–Deficient Human Macrophages , 2000, The Journal of experimental medicine.

[24]  J. Davidson,et al.  CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism , 2004, Angiogenesis.

[25]  I. Ekiel,et al.  Structural basis for different inhibitory specificities of human cystatins C and D. , 1998, Biochemistry.

[26]  R. Lechler,et al.  Isolation of endothelial cells from murine tissue. , 2000, Journal of immunological methods.